Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer
- People who are currently on their third cycle of taxane (a type of chemotherapy) treatment
- People whose medical oncologist has given approval for them to take part in the trial
- People who have experienced some level of numbness or tingling in their hands or feet in the past 7 days — any level except "none" counts
- People who have access to a smartphone or similar device that can be used in a waiting room to complete an online questionnaire
Who may not be able to join:
- People who are unable to read or speak English
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel L Hertz, University of Michigan Rogel Cancer Center
Phone: 734-763-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in decision preparedness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.